Defining chronic rejection in vascularized composite allotransplantation—The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation
Christina L. Kaufman(University of Louisville), Emmanuel Morélon(Université Claude Bernard Lyon 1), Bohdan Pomahač(Yale University), Hatem Amer(Mayo Clinic), Mandeep R. Mehra(Harvard University), Annemarie Weißenbacher(Innsbruck Medical University), Gerald Brandacher(Innsbruck Medical University), Bernhard Zelger(Innsbruck Medical University), Linda C. Cendales(Emory University), Bettina Zelger(Innsbruck Medical University), Sue V. McDiarmid(Ronald Reagan UCLA Medical Center), Jean Kanitakis(Hôpital Lyon Sud)
Cited by 32
Related Papers
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
The promise of organ and tissue preservation to transform medicine
|Nature Biotechnology|2017|530
The International Registry on Hand and Composite Tissue Transplantation
|Transplantation|2008|410
Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
|American Journal of Transplantation|2012|395
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389